GLOBIN SWITCHING Trademark

Trademark Overview


On Tuesday, May 27, 2025, a trademark application was filed for GLOBIN SWITCHING with the United States Patent and Trademark Office. The USPTO has given the GLOBIN SWITCHING trademark a serial number of 99204288. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Tuesday, April 14, 2026. This trademark is owned by Cellarity, Inc.. The GLOBIN SWITCHING trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Research and development of new products in the nature of pharmaceutical, therapeutic and biopharmaceutical preparations and agents; research and development of technology in the field of medicine and diagnostic testing featuring pharmaceutical, therapeutic and biopharmaceutical preparations and agents; pharmaceutical drug development and research; scientific research in the field of drug discovery and development; biomedical research services; pharmaceutical drug development services, namely, preclinical development of therapeutic products; bioinformatic services in the nature of scientific research, namely, collecting and analyzing complex biological data through the use of artificial intelligence; providing temporary use of non-downloadable artificial intelligence (AI) computer software for molecular design in the fields of pharmaceutical research, medicine, and diagnostic testing for disease; scientific diagnostic and screening services for scientific research purposes, namely, con...

Pharmaceutical, therapeutic and biopharmaceutical preparations and agents for the treatment of cancer, autoimmune disorders, transplant rejections, inflammatory disease, immunological disorders, metabolic disorders, neurological disorders, genetic disorders, psychiatric disorders, gastroenterological disorders, renal disorders, cardiovascular disorders, dermatological disorders, respiratory disorders

Medical diagnostic and screening services in the fields of medicine, diagnostic testing, molecular evaluation, and combating of diseases utilizing artificial intelligence and molecular research

General Information


Serial Number99204288
Word MarkGLOBIN SWITCHING
Filing DateTuesday, May 27, 2025
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateTuesday, April 14, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesResearch and development of new products in the nature of pharmaceutical, therapeutic and biopharmaceutical preparations and agents; research and development of technology in the field of medicine and diagnostic testing featuring pharmaceutical, therapeutic and biopharmaceutical preparations and agents; pharmaceutical drug development and research; scientific research in the field of drug discovery and development; biomedical research services; pharmaceutical drug development services, namely, preclinical development of therapeutic products; bioinformatic services in the nature of scientific research, namely, collecting and analyzing complex biological data through the use of artificial intelligence; providing temporary use of non-downloadable artificial intelligence (AI) computer software for molecular design in the fields of pharmaceutical research, medicine, and diagnostic testing for disease; scientific diagnostic and screening services for scientific research purposes, namely, conducting scientific diagnostic testing and evaluation of molecules developed through artificial intelligence means for the combating of diseases; scientific research, namely, research and analysis services in the fields of artificial intelligence and machine learning analytics and research relating to drug development; providing on-line non-downloadable artificial intelligence (AI) software for the capture, collection, conversion, analysis, transmission, processing, receiving, recording, storage and transmission of data, images, information in the fields of healthcare, biomedical and genomic research; providing on-line non-downloadable artificial intelligence (AI) software featuring machine learning for data analysis in the fields of healthcare, biomedical and genomic research; providing on-line non-downloadable artificial intelligence (AI) software featuring machine learning for drug analysis in drug discovery and development; scientific research, namely, research and analysis services in the scientific fields of artificial intelligence and machine learning analytics, healthcare, biomedical and genomic research; providing on-line non-downloadable artificial intelligence (AI) software featuring machine learning for collecting, analyzing, assessing, interpreting and predicting medical, health, transcriptional, genetic, genomic, pharmacogenomic, nutrigenomic, microbiomic, metabolomic, proteomic, biochemistry, and biomarker information, associations, conditions, outcomes, effects and risks in the field of scientific research; medical research services, namely, conducting diagnostic testing and evaluation of molecules developed through artificial intelligence means for the combating of diseases
Goods and ServicesPharmaceutical, therapeutic and biopharmaceutical preparations and agents for the treatment of cancer, autoimmune disorders, transplant rejections, inflammatory disease, immunological disorders, metabolic disorders, neurological disorders, genetic disorders, psychiatric disorders, gastroenterological disorders, renal disorders, cardiovascular disorders, dermatological disorders, respiratory disorders
Goods and ServicesMedical diagnostic and screening services in the fields of medicine, diagnostic testing, molecular evaluation, and combating of diseases utilizing artificial intelligence and molecular research

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, May 27, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, May 27, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, May 27, 2025
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCellarity, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSomerville, MA 02143
US

Trademark Events


Event DateEvent Description
Tuesday, May 27, 2025NEW APPLICATION ENTERED
Tuesday, May 27, 2025APPLICATION FILING RECEIPT MAILED
Friday, October 3, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, October 15, 2025ASSIGNED TO EXAMINER
Wednesday, October 15, 2025NON-FINAL ACTION WRITTEN
Wednesday, October 15, 2025NON-FINAL ACTION E-MAILED
Wednesday, October 15, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, January 6, 2026APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Tuesday, January 6, 2026APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Tuesday, April 14, 2026TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, April 14, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 14, 2026TEAS/EMAIL CORRESPONDENCE ENTERED